3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Genitourinary
1
Gastrointestinal
1
Breast
1
Conditions
Pancreatic Neoplasms
9
Breast Neoplasms
9
Colorectal Neoplasms
7
Ovarian Neoplasms
5
Sarcoma
4
Prostatic Neoplasms
4
Neoplasms
4
Colonic Neoplasms
4
Melanoma
3
Lymphoma, Non-Hodgkin
3
Lung Neoplasms
3
Glioma
3
Carcinoma, Hepatocellular
3
Wilms Tumor
2
Urinary Bladder Neoplasms
2
Sarcoma, Ewing
2
Rhabdomyosarcoma
2
Rhabdoid Tumor
2
Rectal Neoplasms
2
Osteosarcoma
2
Neuroectodermal Tumors, Primitive, Peripheral
2
Neuroblastoma
2
Multiple Myeloma
2
Medulloblastoma
2
Inflammation
2
Histiocytosis, Langerhans-Cell
2
Hepatoblastoma
2
Hematologic Neoplasms
2
Head and Neck Neoplasms
2
Gastrointestinal Neoplasms
2
Interventions
palbociclib
1
X-Rays
1
Technetium Tc 99m Sulfur Colloid
1
Rivaroxaban
1
Radiotherapy, Conformal
1
Photons
1
Heparin, Low-Molecular-Weight
1
Enoxaparin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Thrombosis
×
palbociclib
×
Gastrointestinal
×
Clear all
NCT06065592
2023-10-06
CAT_PB
Lebanese University
Phase 1
Unknown
500 enrolled